Founded in 1886 and headquartered in New Brunswick, New Jersey, Johnson & Johnson (J&J) is a global healthcare leader. Following the 2023 spin-off of its consumer health business (Kenvue), the company has transitioned into a focused enterprise dedicated to Innovative Medicine (Oncology, Immunology, Neuroscience) and MedTech (Surgery, Orthopaedics, Cardiovascular). Guided by its historic “Our Credo,” J&J blends rigorous science with a mission to change the trajectory of health for humanity. As of 2026, it remains one of the world’s most valuable companies, distinguished by its AAA credit rating and relentless investment in R&D.
Here are some articles to give you a basic understanding of the company:
Below is a list of articles for the company:
-
J&J – 2025Q3 report
Here is the detailed summary of the J&J 3Q 2025 10-Q report: Based on the Johnson & Johnson 3Q 2025 10-Q report, here is the detailed summary regarding the talc litigation: Based on the Johnson & Johnson 3Q 2025 10-Q report, here is the Income Statement summary and Segment Revenue analysis (Amounts in USD billions):…
-
J&J – Competitions
Based on Johnson & Johnson’s (JNJ) full-year 2024 financial results and Q3 2025 performance updates, the company operates through two primary segments following the spin-off of its consumer health business (Kenvue). Revenue Ranking by Segment (Full-Year 2024) Business Segment 2024 Revenue (USD) % of Total Revenue Key Growth Drivers Innovative Medicine $56.96 Billion 64.1% Darzalex,…
-
J&J – History
The history of Johnson & Johnson (J&J) spans over 135 years, evolving from a small surgical dressing supplier to a global healthcare leader. It can be divided into five major phases: 1. The Foundation and Sterile Revolution (1886–1910) Founded by brothers Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, the company was inspired…